期刊文献+

Lipozyme TL IM催化合成Temsirolimus 被引量:2

Catalytic Synthesis of Temsirolimus by Lipozyme TL IM
下载PDF
导出
摘要 在脂肪酶Lipozyme TL IM的催化下,2,2,5-三甲基-1,3-二氧六环-5-羧酸酐对抗生素西罗莫司的42-位羟基进行区域选择性酯化制得化合物4;4水解后合成了西罗莫司脂化物Temsirolimus,总产率83.7%。其结构经1H NMR和HR-MS确证。 Temsirolimus was prepared by regioselective esterification at the 42-hydroxy of sirolimus using 2,2,5-trimethyl-1,3-dioxane-5-carboxylic anhydride as the esterifying agent and Lipozyme TL IM as the catalyst to give intermediate 4,followed by hydrolysis.The total yield was 83.7% and the structure was confirmed by 1H NMR and HR-MS.
出处 《合成化学》 CAS CSCD 北大核心 2012年第2期248-250,259,共4页 Chinese Journal of Synthetic Chemistry
基金 国家自然科学基金资助项目(20972153)
关键词 西罗莫司 LIPOZYME TL IM TEMSIROLIMUS 酯化反应 药物合成 sirolimus Lipozyme TL IM temsirolimus esterification drug synthesis
  • 相关文献

参考文献8

  • 1Vignot S,Falvre S,Agulrre D. mTOR-targeted therapy of cancer with rapamycin derivatives[J].Annals of Oncology,2005,(04):525-537.doi:10.1093/annonc/mdi113.
  • 2Kerjaschki D. How to control lymphangio-genesis:A novel role for rapamycin[J].Kidney International,2007,(08):717-719.doi:10.1038/sj.ki.5002184.
  • 3Petricoin E F,Espina V,Araujo R P. Phosphoprotein pathway mapping:Akt/mammalian target of rapamycin activation is negatively associated with childhood rhab domyosarcoma survival[J].Cancer Research,2007,(07):3431-3440.doi:10.1158/0008-5472.CAN-06-1344.
  • 4Jerauld S. Rapamycin hydroxyesters[P].US,5 362718,1994.
  • 5段煜,杜宗良,李瑞霞,吴大诚.天然多羟基化合物在酶催化下的选择性酯化[J].天然产物研究与开发,2006,18(4):702-708. 被引量:3
  • 6熊小龙,杜鹏飞,金鹏,王秋岩,谢恬.脂肪酶催化药物合成的研究进展[J].化学与生物工程,2010,27(8):1-7. 被引量:14
  • 7张中义,吴新侠.脂肪酶在手性药物制备中的应用[J].食品与药品,2007,9(07A):40-43. 被引量:9
  • 8Jianxin G,Mark E R,Ping C. Lipase-catalyzed regioselective esterification of rapamycin:Synthesis of Temsirolimus(CCI-779)[J].Organic Letters,2005,(18):3945-3948.

二级参考文献65

  • 1熊健,季峥,吴坚平,徐刚,杨立荣.有机介质中脂肪酶催化转酯化反应拆分苯乙氰醇的研究[J].生物加工过程,2005,3(3):33-37. 被引量:5
  • 2尹春华,刘涛,谭天伟.Synthesis of Vitamin A Esters by Immobilized Candida sp. Lipase in Organic Media[J].Chinese Journal of Chemical Engineering,2006,14(1):81-86. 被引量:19
  • 3Barr IG,Sjolander A,Cox JC.ISCOMs and other saponin based adjuvants.Advanced Drug Delivery Reviews,1998,32:247-271.
  • 4Mimaki Y,Kuroda M,Kameyame A,et al.Cholestane glycosides with potent cytostatic activities on various tumor cells from Ornithogalum saundersiae bulbs.Bioorganic Medicinal Chemistry Letters,1997,7:633-636.
  • 5Melzig MF,Bader G,Loose R.Investigation of the mechanism of membrane activity of selected triterpenoid saponins.Planta Medica,2001,67:43-48.
  • 6Attele AS,Wu JA,Yuan CS.Ginseng pharmacology:Multiple constituents and multiple actions.Biochemical Pharmacology,1999,58:1685-1693.
  • 7Wu JY,Lidong L,Foo-tim Ch.Ultrasound-assisted extraction of ginseng saponins from ginseng roots and cultured ginseng cells.Ultrasonics Sonochemistry,2001,8:347-352.
  • 8Du Q,Jerz G,Waibel R,et al.Isolation of dammarane saponins from Panax notoginseng by high-speed counter-current chromatography.J Chromatography A,2003,1008:173-180.
  • 9Wu GS,Qin M,Xu JD,et al.Glycosides in the leaves of Oplopana elatus Nakai.Chin Pharm J,1996,31:522-544.
  • 10Jung MT,Jeon BS,Bock JY.Free,esterified,and insolublebound phenolic acids in white and red Korean ginsengs (Panax ginseng C.A.Meyer).Food Chemistry,2002,79:105-111

共引文献23

同被引文献37

  • 1贾薇(编译),宫平(审校).Temsirolimus(Torisel)[J].中国药物化学杂志,2007,17(6):407-407. 被引量:1
  • 2Hudes G,Carducci M,Tomczak P. Temsirolimus,interferon alfa,or both for advanced renal-cell carcinoma[J].{H}New England Journal of Medicine,2007,(22):2271-2281.
  • 3Sorbera L A,Castaner J,Del Fresno M. CCI-799:Oncolytic mTOR inhibitor[J].{H}Drugs of the Future,2002,(1):7-13.
  • 4Gu J X,Ruppen M E,Cai P. Lipase-catalyzed regioselective esterification of rapamycin:synthesis of Temsirolimus (CCI-779)[J].{H}Organic Letters,2005,(18):3945-3948.
  • 5Carlisi D,D'Anneo A,Angileri L,et al.Parthenolide sensitizes hepatocellular carcinoma cells to trail by inducing the expression of death receptors through inhibition of STAT3 activation [J].J Cell Physioh 2011,226(6):1632-1641.
  • 6Cheng G,Xie L.Parthenolide induces apoptosis and cell cycle arrest of human 5637 bladder cancer cells in vitro [J].Molecules,2011,16(8):6758-6768.
  • 7MitaM,Sankhala K,Abdel-Karim I,et al.Deforolimus (AP23573)a novel mTOR inhibitor in clinical development [J].Expert Opin Inv Drug,2008,17(12):1947-1954.
  • 8Wan Xt Shen N,Mendoza A,et al.CCI-779 Inhibits rhabdomyosarcoma xenograft growth by an antiangiogenic mechanism linked to the targeting of mTOR/Hif- 1α/VEGF signaling [J].Neoplasia,2006,8(5):394-401.
  • 9施康尼基JS,利昂尼CL,施泽GA,等.雷帕霉素羟基酯,它们的制备方法及其药用组合物:中国.CN1149296[P].1997-05-07.
  • 10邵CC,塞尔斯特德特JH,诺雷尔丁 R,等.雷帕霉素衍生物的区域选择性合成方法:中国.CN1402731[P].2003-03-12.

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部